Search research articles
Contact Us
Filters
Showing results (381-390 of 437) with videos related to
Page
of 44
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 2015
Genetic investigation of MHC-independent missing-self recognition by mouse NK cells using an in vivo bone marrow transplantation model
Peter Chen, Oscar A Aguilar, Mir Munir A Rahim, et al.
Practical Radiation Oncology
|
May 4, 2023
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Interstitial Brachytherapy Is Safe: First Results From the Tri-fraction Radiation Therapy Used to Minimize Patient Hospital Trips (TRIUMPH-T) Trial
Catheryn Yashar, Atif J Khan, Peter Chen, et al.
CJC Open
|
January 24, 2022
Short-term and Long-term Risk of Stroke in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: Systematic Review and Meta-analysis
Michael K Wang, Pascal B Meyre, Rachel Heo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 24, 2020
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia
Stanley C Jordan, Phillip Zakowski, Hai P Tran, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Targeting a macrophage stemness factor to mitigate diseases post respiratory viral infection
Mohd Arish, Arka Sen Chaudhuri, Janli Tang, et al.
JAMA Oncology
|
March 31, 2017
Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy
Meena S Moran, Yinjun Zhao, Shuangge Ma, et al.
Clinical Pharmacology and Therapeutics
|
August 29, 2021
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19
Peter Chen, Gourab Datta, Ying Grace Li, et al.
Infectious Diseases and Therapy
|
June 17, 2023
Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial
Himanshu P Upadhyaya, Jenny Y Chien, Amanda J Long, et al.
Frontiers in Immunology
|
December 27, 2021
Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together
Lin Zhang, Josh Poorbaugh, Michael Dougan, et al.
JCI Insight
|
December 13, 2016
miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways
Lingyin Ge, David M Habiel, Phil M Hansbro, et al.
Page
of 44
Search research articles
Search
Showing results (381-390 of 437) with videos related to
Sort By:
Page
of 44
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 2015
Genetic investigation of MHC-independent missing-self recognition by mouse NK cells using an in vivo bone marrow transplantation model
Peter Chen, Oscar A Aguilar, Mir Munir A Rahim, et al.
Practical Radiation Oncology
|
May 4, 2023
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Interstitial Brachytherapy Is Safe: First Results From the Tri-fraction Radiation Therapy Used to Minimize Patient Hospital Trips (TRIUMPH-T) Trial
Catheryn Yashar, Atif J Khan, Peter Chen, et al.
CJC Open
|
January 24, 2022
Short-term and Long-term Risk of Stroke in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: Systematic Review and Meta-analysis
Michael K Wang, Pascal B Meyre, Rachel Heo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 24, 2020
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia
Stanley C Jordan, Phillip Zakowski, Hai P Tran, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Targeting a macrophage stemness factor to mitigate diseases post respiratory viral infection
Mohd Arish, Arka Sen Chaudhuri, Janli Tang, et al.
JAMA Oncology
|
March 31, 2017
Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy
Meena S Moran, Yinjun Zhao, Shuangge Ma, et al.
Clinical Pharmacology and Therapeutics
|
August 29, 2021
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19
Peter Chen, Gourab Datta, Ying Grace Li, et al.
Infectious Diseases and Therapy
|
June 17, 2023
Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial
Himanshu P Upadhyaya, Jenny Y Chien, Amanda J Long, et al.
Frontiers in Immunology
|
December 27, 2021
Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together
Lin Zhang, Josh Poorbaugh, Michael Dougan, et al.
JCI Insight
|
December 13, 2016
miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways
Lingyin Ge, David M Habiel, Phil M Hansbro, et al.
Page
of 44